User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

6062

Interactions with Platform & by Email *

INTERACTIONS

970

Unique # Participated *

PARTICIPANTS

182

Responses Validated *

VALIDATIONS

39

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Market Primer.....II-11$100
   Major Neurostimulation Therapies and Indications At A Glance.....II-21$100
   Outlook.....II-3 1$100
   Table 1: Global Neurostimulation Market - Product Segments Ranked by CAGR (Value Sales) for 2014-2020: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart).....II-41$350
   Developed Markets: Traditional Revenue Contributors.....II-51$100
   Developing Countries Turbo Charge Future Market Growth.....II-6
Table 2: Global Neurostimulation Market - Geographic Regions Ranked by CAGR (Value Sales) for 2014-2020: Asia-Pacific, Latin America, Rest of World, Europe, Japan, US, and Canada (includes corresponding Graph/Chart).....II-6
Spinal Cord Stimulation (SCS): A Rapidly Evolving Market.....II-6
2$350
   Few Players Dominate Neurostimulation Market.....II-8
Worldwide Neurostimulation Market: Leading Players by Product Segment.....II-8
1$100
   Table 3: Leading Players in the Global Neurostimulation Devices Market (2014): Percentage Share Breakdown of Value Sales for Medtronic, Boston Scientific, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart).....II-9
FDA-Approved Products of Leading Players in the Neurostimulation Market.....II-9
Select Neuromodulation Products under Development.....II-9
1$350
   Companies Researching Neurostimulator Applications by Indication.....II-10
Competition in the PNS Space.....II-10
1$100
   New Indications Expand Opportunities for Growth.....II-111$100
   Growing Awareness and Acceptance Among Physicians.....II-12
Neuropathic Pain: A Highly Underserved Market.....II-12
1$100
   Peripheral Nerve Stimulation (PNS): A Potential Area for Pain Management
  Devices.....II-13
Occipital Nerve Stimulation (ONS): An Untapped Market with Potential.....II-13
Steering Brain Stimulation – An Emerging Concept in DBS.....II-13
1$100
   Novel Applications Bode Tremendous Prospects.....II-14
Obesity Control to Spur Market Growth in Future.....II-14
1$100
   Table 4: Obese and Overweight, and Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart).....II-15

Table 5: Global Obesity Population by Region/Country: 2013 (includes corresponding Graph/Chart).....II-15
1$350
   Powering Neurostimulation Devices- The Key to Success.....II-16
Closed-Loop Functionality Gaining Favor over Open-Loop in Neurostimulation.....II-16
1$100
   Device Programmability Gains Precedence in Device Choice.....II-17
Novel Electrode Configurations Aid in Localization and Side Effect Reduction.....II-17
Advances in Programming Promise Ease of Treatment.....II-17
1$100
   Vagus Nerve Stimulation for Treating Obesity.....II-18
Trigeminal Nerve Stimulation – A Promising Area.....II-18
1$100
   Nanotechnology – The Future of DBS Electrodes.....II-19
Synergy with Pharma & Biotech Companies Creates New Avenues.....II-19
1$100
   Third-Party Reimbursement – A Vital Role to Play.....II-20
Outsourcing – A Growing Phenomenon.....II-20
Chip Makers Struggle to Meet Quality Demand.....II-20
Product Complexity: A Cause of Concern.....II-20
1$100
   Concerns Remain Afloat – Affecting Adoption.....II-211$100
   Hardware-related Infections – A Major Concern.....II-22
Battery Life – A Bone of Contention for Neurostimulation.....II-22
1$100
   Neurostimulation Market Marked by High Entry Barriers.....II-231$100
   Ballooning Global Population Offers Significant Growth Opportunities.....II-24
Table 6: Top 25 Countries Worldwide in Terms of Population (2010 & 2013) (includes corresponding Graph/Chart).....II-24
1$350
   Aging Global Population: A Major Growth Propeller.....II-25
Demographic Statistics of Aging Populace: Unfurling the Market Potential.....II-25
Table 7: Aging (65+) Demographics as a Percentage of Total Population for Major Countries: 2000, 2011, and 2020 (includes corresponding Graph/Chart).....II-25
1$350
   Table 8: Global Aging Population (in Thousands) by Age Group: 1975, 2000, 2025, and 2050 (includes corresponding Graph/Chart).....II-261$350
   Table 9: Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart).....II-271$350
   Longer Life Expectancy Bolsters Market Growth.....II-28
Table 10: Life Expectancy for Select Countries in Number of Years (2015E) (includes corresponding Graph/Chart).....II-28
1$350
   Table 11: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050 (includes corresponding Graph/Chart).....II-29
Rising Disposable Incomes Propel Market Growth.....II-29
1$350
   Table 12: Annual Disposable Incomes in US$ Thousand for Select Countries (2012) (includes corresponding Graph/Chart).....II-301$350
   Table 13: Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P (includes corresponding Graph/Chart).....II-31
Improving Healthcare Expenditure to Foster Growth.....II-31
1$350
   Table 14: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart).....II-32

Table 15: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart).....II-32
1$350
   RNS Assists Medical Practitioners in Treating Critical Neurological Ailments.....II-331$100
   Investigational DBS Device Inches towards Closed-Loop Functionality.....II-34
Closed-Loop Stimulation – A Potential Solution for Gait Disturbances in DBS Treated PD
  Patients.....II-34
1$100
   Vagus Nerve Stimulator Offers Safe and Reliable Epilepsy Treatment for
  Patients.....II-35
1$100
   AspireSR Neurostimulator Mitigates Requirement of Brain Surgery.....II-36
AspireSR Neurostimulator Gains Momentum.....II-36
1$100
   Medtronic’s SCS System Brings Paradigm Shift in Neurostimulators Market.....II-37
Equilia System Provides Cost-Effective Treatment for Cardiovascular Patients.....II-37
1$100
   Portable Neuromodulation Device to Improve Walking in Multiple Sclerosis
  Patients.....II-38
Emerging PNS Technologies to Drive Neuromodulation Device Market.....II-38
1$100
   Mainstay ReActive8.....II-39
SMARTPATCH PNS System from SPR Therapeutics.....II-39
1$100
   Neuros Medical’s Electrical Nerve Block Technology.....II-40
I-Patch from Direct Spinal Therapeutics.....II-40
Valtronic and NDI Medical to Develop Miniature Implantable Pulse Generator.....II-40
1$100
   Neuromodulation Device for Obstructive Sleep Apnea Treatment.....II-41
SetPoint Medical’s Vagus Nerve Stimulation Technology.....II-41
1$100
   Other Potential Applications for PNS Technology.....II-421$100
   Parkinson’s Disease – The Largest Application Market for DBS.....II-431$100
   A Note on Incidence and Prevalence of Parkinson’s Disease.....II-44
Table 16: Global Prevalence of Parkinson’s Disease (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart).....II-44
Research Suggests Greater Benefits of DBS in Parkinson’s.....II-44
1$350
   Incidence and Prevalence of Essential Tremor.....II-45
DBS in Dystonia.....II-45
1$100
   Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical
  Studies and Meta-Analyses.....II-46
1$100
   Dystonia Patient Selection Criteria for DBS.....II-47
DBS in OCD.....II-47
DBS in Epilepsy Treatment.....II-47
1$100
   Table 17: Global Prevalence of Epilepsy (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart).....II-481$350
   DBS in Tourette Syndrome – Research Progress So Far.....II-49
Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select
  Clinical Studies and Meta-Analyses.....II-49
1$100
   Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment.....II-501$100
   Multiple Possible Targets Deter Progress of DBS in Depression Treatment.....II-511$100
   Overview of Select Studies on DBS in Depression Treatment.....II-521$100
   SCC – A Promising Target for Stimulation in Depression.....II-53
Eating Disorders - A Note on Potential of DBS.....II-53
1$100
   DBS in Obesity – Animal Models Show Promise.....II-54
Anorexia Treatment – Where Does DBS Stand?.....II-54
DBS in Dementia Treatment – Animal Studies Bode Well for Efficacy in Humans.....II-54
1$100
   Prospects of DBS in Chronic Pain Management.....II-55
SNS for Incontinence.....II-55
1$100
   Types of Incontinence and Features/Causes for Incontinence.....II-56 1$100
   Table 18: Worldwide Prevalence (%) of Urinary Incontinence in Men and Women (includes corresponding Graph/Chart).....II-571$350
   Table 19: Worldwide Prevalence of Stress UI in Women in the Age Group of 15 to 85+ Years by Select Geographic Region: 2013-2020 (includes corresponding Graph/Chart).....II-58
Sleep Apnea.....II-58
1$350
   Introduction to Neurostimulator.....II-59
A Historical Note.....II-59
Neurostimulation Devices by Product Segment.....II-59
1$100
   Spinal Cord Stimulation (SCS).....II-601$100
   SCS – What it Treats .....II-61
Segmentation by Type of Power Source.....II-61
Implantable Pulse Generator Systems (IPGs).....II-61
Radio Frequency (RF) Systems.....II-61
1$100
   Market Assessment for RF Systems.....II-62
Sacral Nerve Stimulation (SNS).....II-62
1$100
   Deep Brain Stimulation (DBS).....II-63
Vagus Nerve Stimulation (VNS).....II-63
1$100
   Gastric Electric Stimulation (GES).....II-64
Stimulation Device – How it Works.....II-64
1$100
   Neurostimulation & its Benefits.....II-65
Prospective Application Areas for Neurostimulators – Select Indications.....II-65
1$100
   Approved Indications for Spinal Cord Stimulation by Geographic Regions.....II-66
Neurostimulation Devices – Technology & Safety Issues.....II-66
1$100
   St. Jude Medical Wins CE Mark Approval for MR- Conditional Rechargeable Spinal Cord
  Stimulator.....II-67
St. Jude Medical Nabs CE Mark for Infinity Deep Brain Stimulation System and
  Directional DBS Lead.....II-67
EndoStim Receives CE Mark Approval for EndoStim II.....II-67
St. Jude Medical Wins Health Canada Approval for Prodigy Spinal Cord
  Stimulator.....II-67
St. Jude Medical Bags FDA Approval for Brio Neurostimulation System for Parkinson's
  Disease.....II-67
Medtronic Receives European Approval of Full-Body MR Conditional Deep Brain Stimulation
  Systems.....II-67
1$100
   AdvaStim Gets Neurostimulation Patent.....II-68
St. Jude Bags EU Regulatory Approval for Prodigy Neurostimulator with Burst
  Technology.....II-68
St. Jude Medical Secures FDA Approval for Protégé™ IPG.....II-68
1$100
   NeuroMetrix Introduces Quell™ Wearable Pain Relief Technology.....II-69
NeuroMetrix Unveils SENSUS Pain Management System.....II-69
Medtronic Rolls Out Neurostimulation Systems for Chronic Pain.....II-69
1$100
   St. Jude Medical Snaps Up Spinal Modulation.....II-70
Allergan Acquires Oculeve.....II-70
Medtronic Takes Over Advanced Uro-Solutions.....II-70
Sorin and Cyberonics Announces Merger.....II-70
Greatbatch Spins Off Algostim.....II-70
Medtronic Takes Over Sapiens Steering Brain Stimulation.....II-70
Kelyniam Global Snaps Up MED-ALLY.....II-70
1$100
   AdvaStim Forays into Neuromodulation Device Market.....II-71
Aurora BioScience Inks Distribution Agreement with Synapse Biomedical.....II-71
Sorin Group Acquires Neurotech.....II-71
St Jude Medical and Spinal Modulation Ink Distribution Agreements.....II-71
Boston Scientific Commences Trial for Neurostimulation Evaluation in Chronic
  Migraine Treatment.....II-71
Spinal Modulation Starts Trial for Neurostim Device.....II-71
1$100
   Aleva Neurotherapeutics SA (Switzerland).....II-72
BioControl Medical (Israel).....II-72
Bioness Inc. (USA).....II-72
1$100
   Boston Scientific Corp. (USA).....II-73
EnteroMedics Inc. (USA).....II-73
LivaNova PLC (UK).....II-73
1$100
   Medtronic, Inc. (USA).....II-74
NeuroPace, Inc. (USA).....II-74
1$100
   NeuroSigma, Inc. (USA).....II-75
Nevro Corp. (USA).....II-75
SPR Therapeutics, LLC (US).....II-75
1$100
   St. Jude Medical, Inc. (USA).....II-76
Synapse Biomedical, Inc. (USA).....II-76
1$100
   Table 20: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-771$350
   Table 21: World Historic Review for Neurostimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-781$350
   Table 22: World 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-791$350
   Table 23: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-801$350
   Table 24: World Historic Review for Spinal Cord Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-811$350
   Table 25: World 14-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-821$350
   Table 26: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-831$350
   Table 27: World Historic Review for Deep Brain Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-841$350
   Table 28: World 14-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-851$350
   Table 29: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-861$350
   Table 30: World Historic Review for Sacral Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-871$350
   Table 31: World 14-Year Perspective for Sacral Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-881$350
   Table 32: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-891$350
   Table 33: World Historic Review for Vagus Nerve Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-901$350
   Table 34: World 14-Year Perspective for Vagus Nerve Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-911$350
   Table 35: World Recent Past, Current & Future Analysis for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart).....II-921$350
   Table 36: World Historic Review for Gastric Electric Stimulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2007 through 2013 (includes corresponding Graph/Chart).....II-931$350
   Table 37: World 14-Year Perspective for Gastric Electric Stimulators by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-941$350
   A. Market Analysis.....III-1
Overview.....III-1
1$75
   Product Segments Ranked by Growth.....III-2
Table 38: Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Revenue Growth (includes corresponding Graph/Chart).....III-2
1$200
   Table 39: Neurostimulation Market in the US (2014-2020): Product Segments Ranked by Unit Sales Growth (includes corresponding Graph/Chart).....III-3
Neurostimulation Indications and Use of Related Devices/Techniques in the
  US.....III-3
1$200
   Potential Growth for Neurostimulation Systems in the US.....III-4
Spinal Cord Stimulation Products Market.....III-4
Sacral Nerve Stimulation Products Market.....III-4
1$75
   Deep Brain Stimulation Products Market.....III-51$75
   Aging Baby Boomers Benefit Market Prospects in the US.....III-6
Table 40: North American Elderly Population by Age Group: 1975, 2000, 2025P, and 2050P (includes corresponding Graph/Chart).....III-6
1$200
   Shift Away from Orthopaedic and Cardiovascular Device Markets.....III-7
Trends in the Embolotherapy Market.....III-7
1$75
   Neurovascular Stents Market Attracting Cardiovascular Companies.....III-8
Migraine Devices – New Frontiers for Neurostimulation.....III-8
Competitive Landscape.....III-8
1$75
   Neurostimulation Device Approvals.....III-9
Product Innovations/Introductions.....III-9
1$75
   Strategic Corporate Developments.....III-101$75
   Select Key Players.....III-114$300
   B. Market Analytics.....III-15
Table 41: US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-15
1$200
   Table 42: US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-161$200
   Table 43: US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-171$200
   Table 44: US Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-181$200
   Table 45: US Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-191$200
   Table 46: US 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-201$200
   A. Market Analysis.....III-21
Outlook.....III-21
Neurostimulation Device Approval.....III-21
1$75
   B. Market Analytics.....III-22
Table 47: Canadian Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-22
1$200
   Table 48: Canadian Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-231$200
   Table 49: Canadian 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-241$200
   Market Analysis.....III-25
Table 50: Japanese Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-25
1$200
   Table 51: Japanese Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-261$200
   Table 52: Japanese 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-271$200
   A. Market Analysis.....III-28
Outlook.....III-28
Increasing Incidence of Neurological Diseases Spur Market Growth.....III-28
Rising Life Expectancy and the Risk of Injury to Drive Demand across Europe.....III-28
1$75
   Table 53: Life Expectancy at 65 Years for Select Countries in Europe: 2012 (includes corresponding Graph/Chart).....III-291$200
   Table 54: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....III-301$200
   Neurostimulation Device Approvals.....III-311$75
   Strategic Corporate Developments.....III-32
Select Key Players.....III-32
2$150
   B. Market Analytics.....III-34
Table 55: European Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 56: European Historic Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   Table 57: European 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-361$200
   Table 58: European Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-371$200
   Table 59: European Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   Table 60: European 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Outlook.....III-40
Neurostimulation Devices Market Exhibits Substantial Growth.....III-40
1$75
   Strategic Corporate Development.....III-41
B. Market Analytics.....III-41
Table 61: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-41
1$200
   Table 62: Asia-Pacific Historic Analysis for Neurostimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-421$200
   Table 63: Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-431$200
   Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-441$200
   Table 65: Asia-Pacific Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-451$200
   Table 66: Asia-Pacific 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-461$200
   Market Analysis.....III-47
Table 67: Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-47
1$200
   Table 68: Latin American Historic Analysis for Neurostimulation Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-481$200
   Table 69: Latin American 14-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-491$200
   Table 70: Latin American Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-501$200
   Table 71: Latin American Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-511$200
   Table 72: Latin American 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-521$200
   A. Market Analysis.....III-53
Outlook.....III-53
Business-Friendly Government Policies Fuels Market Growth.....III-53
BioControl Medical – A Major Israeli Player.....III-53
1$75
   B. Market Analytics.....III-54
Table 73: Rest of World Recent Past, Current & Future Analysis for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-54
1$200
   Table 74: Rest of World Historic Review for Neurostimulation Devices by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-551$200
   Table 75: Rest of World 14-Year Perspective for Neurostimulation Devices by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-561$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com